We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Why Biotech And Pharma Patents Survive IPR

Law360 (November 21, 2018, 1:36 PM EST) -- When the America Invents Act of 2011 ushered in a number of new administrative procedures for challenging issued patents, the biotechnology and pharmaceutical industries at first seemed largely unconcerned. The new...
To view the full article, register now.